BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9973418)

  • 1. Measles virus infection synergizes with IL-4 in IgE class switching.
    Imani F; Proud D; Griffin DE
    J Immunol; 1999 Feb; 162(3):1597-602. PubMed ID: 9973418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells.
    Schnorr JJ; Dunster LM; Nanan R; Schneider-Schaulies J; Schneider-Schaulies S; ter Meulen V
    Eur J Immunol; 1995 Apr; 25(4):976-84. PubMed ID: 7737301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD46 in measles virus infection in CD46 transgenic mice.
    Blixenkrone-Møller M; Bernard A; Bencsik A; Sixt N; Diamond LE; Logan JS; Wild TF
    Virology; 1998 Sep; 249(2):238-48. PubMed ID: 9791016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a T cell membrane protein possibly involved in IL-4-induced B cell immunoglobulin class switching to IgE.
    Matsushita S; Katz DH
    Cell Immunol; 1994 Feb; 153(2):378-91. PubMed ID: 8118870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of human B lymphocytes with MMR vaccine induces IgE class switching.
    Imani F; Kehoe KE
    Clin Immunol; 2001 Sep; 100(3):355-61. PubMed ID: 11513549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549.
    Helin E; Vainionpää R; Hyypiä T; Julkunen I; Matikainen S
    Virology; 2001 Nov; 290(1):1-10. PubMed ID: 11882993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is mRNA and protein level of CD46 altered in measles virus vaccine strain S191-infected cells?
    Hu C; Qi Y; Zhang P; Liu X; Xu Q; Chen X
    Biochem Biophys Res Commun; 2004 Sep; 322(3):794-802. PubMed ID: 15336534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction.
    Patterson JB; Scheiflinger F; Manchester M; Yilma T; Oldstone MB
    Virology; 1999 Mar; 256(1):142-51. PubMed ID: 10087234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response.
    Gauvrit A; Brandler S; Sapede-Peroz C; Boisgerault N; Tangy F; Gregoire M
    Cancer Res; 2008 Jun; 68(12):4882-92. PubMed ID: 18559536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of measles virus (Hallé strain) with CD46: evidence that a common binding site on CD46 facilitates both CD46 downregulation and MV infection.
    Lecouturier V; Rizzitelli A; Fayolle J; Daviet L; Wild FT; Buckland R
    Biochem Biophys Res Commun; 1999 Oct; 264(1):268-75. PubMed ID: 10527876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V and C proteins of measles virus function as virulence factors in vivo.
    Patterson JB; Thomas D; Lewicki H; Billeter MA; Oldstone MB
    Virology; 2000 Feb; 267(1):80-9. PubMed ID: 10648185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
    Anderson BD; Nakamura T; Russell SJ; Peng KW
    Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of NF-kappaB and AP-1 activation in monocytic cells persistently infected with measles virus.
    Indoh T; Yokota S; Okabayashi T; Yokosawa N; Fujii N
    Virology; 2007 May; 361(2):294-303. PubMed ID: 17196632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles virus: immunomodulation and cell tropism as pathogenicity determinants.
    Schneider-Schaulies S; Schneider-Schaulies J; Niewiesk S; Ter Meulen V
    Med Microbiol Immunol; 2002 Oct; 191(2):83-7. PubMed ID: 12410346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface.
    Klagge IM; ter Meulen V; Schneider-Schaulies S
    Eur J Immunol; 2000 Oct; 30(10):2741-50. PubMed ID: 11069053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles virus targets DC-SIGN to enhance dendritic cell infection.
    de Witte L; Abt M; Schneider-Schaulies S; van Kooyk Y; Geijtenbeek TB
    J Virol; 2006 Apr; 80(7):3477-86. PubMed ID: 16537615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells.
    Rager KJ; Langland JO; Jacobs BL; Proud D; Marsh DG; Imani F
    J Virol; 1998 Feb; 72(2):1171-6. PubMed ID: 9445015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.